JPMorgan Chase & Co’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-100
| Closed | -$66 | – | 6599 |
|
2024
Q2 | $66 | Hold |
100
| – | – | ﹤0.01% | 5946 |
|
2024
Q1 | $61 | Buy |
100
+11
| +12% | +$7 | ﹤0.01% | 5980 |
|
2023
Q4 | $52 | Hold |
89
| – | – | ﹤0.01% | 6162 |
|
2023
Q3 | $59 | Hold |
89
| – | – | ﹤0.01% | 6014 |
|
2023
Q2 | $293 | Sell |
89
-11,981
| -99% | -$39.4K | ﹤0.01% | 5687 |
|
2023
Q1 | $110K | Buy |
12,070
+3,975
| +49% | +$36.2K | ﹤0.01% | 4606 |
|
2022
Q4 | $95K | Buy |
8,095
+4,505
| +125% | +$52.9K | ﹤0.01% | 4506 |
|
2022
Q3 | $76K | Buy |
3,590
+71
| +2% | +$1.5K | ﹤0.01% | 4573 |
|
2022
Q2 | $85K | Sell |
3,519
-409
| -10% | -$9.88K | ﹤0.01% | 4702 |
|
2022
Q1 | $196K | Buy |
3,928
+1,447
| +58% | +$72.2K | ﹤0.01% | 4460 |
|
2021
Q4 | $174K | Sell |
2,481
-4,590
| -65% | -$322K | ﹤0.01% | 4605 |
|
2021
Q3 | $659K | Buy |
7,071
+4,631
| +190% | +$432K | ﹤0.01% | 3826 |
|
2021
Q2 | $245K | Buy |
2,440
+139
| +6% | +$14K | ﹤0.01% | 4394 |
|
2021
Q1 | $214K | Sell |
2,301
-383
| -14% | -$35.6K | ﹤0.01% | 4428 |
|
2020
Q4 | $221K | Buy |
2,684
+547
| +26% | +$45K | ﹤0.01% | 4120 |
|
2020
Q3 | $191K | Sell |
2,137
-3,077
| -59% | -$275K | ﹤0.01% | 3756 |
|
2020
Q2 | $485K | Buy |
5,214
+3,579
| +219% | +$333K | ﹤0.01% | 3310 |
|
2020
Q1 | $46K | Sell |
1,635
-5,045
| -76% | -$142K | ﹤0.01% | 4164 |
|
2019
Q4 | $277K | Buy |
6,680
+5,763
| +628% | +$239K | ﹤0.01% | 3706 |
|
2019
Q3 | $13K | Buy |
917
+149
| +19% | +$2.11K | ﹤0.01% | 4547 |
|
2019
Q2 | $25K | Buy |
+768
| New | +$25K | ﹤0.01% | 4483 |
|
2018
Q3 | – | Sell |
-11
| Closed | -$1K | – | 4906 |
|
2018
Q2 | $1K | Sell |
11
-637
| -98% | -$57.9K | ﹤0.01% | 4727 |
|
2018
Q1 | $68K | Sell |
648
-1,966
| -75% | -$206K | ﹤0.01% | 4051 |
|
2017
Q4 | $335K | Buy |
+2,614
| New | +$335K | ﹤0.01% | 3507 |
|